Workflow
威高血净(603014.SH)：拟对威高泰尔茂增资0.725亿元
Shandong Weigao Blood Purification ProductsShandong Weigao Blood Purification Products(SH:603014) Ge Long Hui A P P·2025-11-20 09:16

Group 1 - The core point of the article is that Weigao Blood Purification (603014.SH) announced a capital increase to support the development of its peritoneal dialysis fluid business [1] - The company plans to invest 72.5 million RMB in Weigao Tailmao (Weihai) Medical Products Co., Ltd. as part of this capital increase [1] - The investment is in collaboration with Tailmao (China) Investment Co., Ltd. to meet the strategic planning needs of the company [1]